1. Home
  2. NTLA vs PDS Comparison

NTLA vs PDS Comparison

Compare NTLA & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • PDS
  • Stock Information
  • Founded
  • NTLA 2014
  • PDS 1951
  • Country
  • NTLA United States
  • PDS Canada
  • Employees
  • NTLA N/A
  • PDS N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PDS
  • Sector
  • NTLA Health Care
  • PDS
  • Exchange
  • NTLA Nasdaq
  • PDS Nasdaq
  • Market Cap
  • NTLA 794.5M
  • PDS 649.5M
  • IPO Year
  • NTLA 2016
  • PDS N/A
  • Fundamental
  • Price
  • NTLA $10.68
  • PDS $50.78
  • Analyst Decision
  • NTLA Buy
  • PDS Buy
  • Analyst Count
  • NTLA 19
  • PDS 1
  • Target Price
  • NTLA $35.11
  • PDS $95.00
  • AVG Volume (30 Days)
  • NTLA 4.9M
  • PDS 120.2K
  • Earning Date
  • NTLA 08-07-2025
  • PDS 07-29-2025
  • Dividend Yield
  • NTLA N/A
  • PDS N/A
  • EPS Growth
  • NTLA N/A
  • PDS N/A
  • EPS
  • NTLA N/A
  • PDS 5.20
  • Revenue
  • NTLA $45,569,000.00
  • PDS $1,301,611,298.00
  • Revenue This Year
  • NTLA N/A
  • PDS $1.35
  • Revenue Next Year
  • NTLA N/A
  • PDS $0.99
  • P/E Ratio
  • NTLA N/A
  • PDS $8.91
  • Revenue Growth
  • NTLA N/A
  • PDS N/A
  • 52 Week Low
  • NTLA $5.90
  • PDS $36.20
  • 52 Week High
  • NTLA $28.18
  • PDS $79.07
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 69.70
  • PDS 62.11
  • Support Level
  • NTLA $8.98
  • PDS $46.44
  • Resistance Level
  • NTLA $11.08
  • PDS $47.83
  • Average True Range (ATR)
  • NTLA 0.69
  • PDS 1.59
  • MACD
  • NTLA 0.16
  • PDS -0.07
  • Stochastic Oscillator
  • NTLA 88.96
  • PDS 74.75

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

Share on Social Networks: